Peter Thornton - Net Worth and Insider Trading
Peter Thornton Net Worth
The estimated net worth of Peter Thornton is at least $2 Million dollars as of 2024-05-01. Peter Thornton is the Director of Avadel Pharmaceuticals PLC and owns about 83,055 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $2 Million. Peter Thornton is also the Director of Agenus Inc and owns about 110 shares of Agenus Inc (AGEN) stock worth over $1,443. Details can be seen in Peter Thornton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Thornton has not made any transactions after 2022-05-27 and currently still holds the listed stock(s).
Transaction Summary of Peter Thornton
Peter Thornton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Thornton owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Agenus Inc (AGEN) .
Click here to see the complete history of Peter Thornton’s form 4 insider trades.
Insider Ownership Summary of Peter Thornton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2022-05-27 | director |
| AGEN | Agenus Inc | 2006-12-07 | CFO & Sr. VP |
Peter Thornton Latest Holdings Summary
Peter Thornton currently owns a total of 2 stocks. Among these stocks, Peter Thornton owns 83,055 shares of Avadel Pharmaceuticals PLC (AVDL) as of May 27, 2022, with a value of $2 Million and a weighting of 99.91%. Peter Thornton also owns 110 shares of Agenus Inc (AGEN) as of December 7, 2006, with a value of $1,443 and a weighting of 0.09%.
Latest Holdings of Peter Thornton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2022-05-27 | 83,055 | 18.41 | 1,529,043 |
| AGEN | Agenus Inc | 2006-12-07 | 110 | 13.12 | 1,443 |
Holding Weightings of Peter Thornton
Peter Thornton Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Thornton has made a total of 1 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 50,000 shares on May 27, 2022, which cost Peter Thornton around $84,500.
According to the SEC Form 4 filings, Peter Thornton has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 0 shares on December 7, 2006, which brought Peter Thornton around $0.
Insider Trading History of Peter Thornton
- 1
Peter Thornton Trading Performance
GuruFocus tracks the stock performance after each of Peter Thornton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Thornton is 78.53%. GuruFocus also compares Peter Thornton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Thornton within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Thornton's insider trading performs compared to the benchmark.
Performance of Peter Thornton
Average Return
199.61%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.88 | 78.53 | 96.57 | 199.61 | -40.79 | -14.11 |
| Relative Return to S&P 500(%) | 3.5 | 76.06 | 93.94 | 190.46 | -50.19 | -23.58 |
Peter Thornton Ownership Network
Ownership Network List of Peter Thornton
Ownership Network Relation of Peter Thornton
Peter Thornton Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Peter Thornton is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Peter Thornton made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Peter Thornton Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Thornton. You might contact Peter Thornton via mailing address: Technopath Life Sciences Park, Fort Henry, Ballina, Co. Tipperary L2 V94 Ff1p.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
